Being active is not the same as being safe. Most companies in Z-Category, suspended, or worse, were "active" 24 months earlier. Pre-emptive advisory is dramatically cheaper than post-crisis revival.
Active listed companies make up the majority of India's listed universe — approximately 7,000 companies trading normally under full LODR coverage. They are doing the regular work of capital markets: filing quarterly results, holding board meetings, disclosing material events, paying listing fees. None of which guarantees they will still be active in 24 months. SEBI's LODR regulations create hundreds of compliance triggers. Each missed event, late filing, or governance lapse accumulates risk. Most companies don't see the drift toward Z-Category until they are already in it.
Reg 30 alone has 35+ enumerated material events plus a qualitative materiality standard. Reg 23 RPT disclosures, Reg 29 board approvals, insider trading code under PIT — the cumulative compliance load is enormous.
Rights issue, preferential allotment, buyback, scheme of arrangement, open offer — each is a multi-month regulatory project requiring specialist orchestration across SEBI, exchanges, NCLT and shareholders.
Composition gaps, missing committee charters, inadequate succession planning, outdated insider trading codes — these don't trigger immediate action but become weaponised in any regulatory investigation.
Companies rarely move to Z-Category in one step. The drift typically starts 4–6 quarters earlier with one missed filing, then another, then a board resignation. By the time the flag is visible, the cure is expensive.
Our internal data on revival cases is unambiguous: companies that engaged for compliance support 12 months before any flag was raised closed their issues for a fraction of the cost — both in fees and in business disruption — compared to companies that engaged only after suspension. The Compliance Health Check is built specifically for this audience: a 5-minute diagnostic that surfaces the drift signals before they become triggers.
A sequenced four-step engagement built around the specific regulatory profile of your category. Modular, stage-wise, and promoter-friendly.
If any of these sound familiar, the situation is more common than you think — and the pathway is well-defined.
A confidential diagnostic call with our R3 team. We'll walk through your case, indicate revival or resolution feasibility, and outline the realistic next step. No fee, no commitment.